Dr. Michael Keene Muhlert, MD

Dr. Muhlert practices at Saint Francis Hospital-Memphis in Memphis, Tennessee, part of Tenet Healthcare.

Dr. Muhlert's NPI, 1063630093, was assigned on April 23, 2007. Dr. Muhlert graduated from University of Texas Medical School at Houston in 2004. Dr. Muhlert holds Tennessee license 42710.

Dr. Muhlert's primary practice is Saint Francis Hospital-Memphis, at 5959 Park Ave, Memphis, TN 38119 in Shelby County. The practice phone is (901) 765-1000.

Dr. Muhlert's primary practice is Saint Francis Hospital-Memphis in Memphis, Tennessee, part of Tenet Healthcare. Dr. Muhlert is also affiliated with Baptist Memorial Hospital-North Mississippi. The medical group on file is Memphis Physicians Radiological Group (MPRG). Dmand AI also links Dr. Muhlert to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muhlert practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Muhlert's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dmand AI has Dr. Muhlert's licenses on file in 4 states: Tennessee, Arkansas, Mississippi and South Carolina.

CMS data shows 4,104 Medicare services from Dr. Muhlert across 73 procedure codes in 2024, for 2,519 Medicare patients. Medicare paid $114,478 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 2,519 Medicare patients who saw Dr. Muhlert in 2024. The largest group is 65 to 74, with 971 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muhlert's median patient age at 59, with 61% women.

In 2024, Dr. Muhlert wrote 66 Medicare Part D claims for 37 patients. 98% of them were for generic drugs. CMS names the drug for 48 of them, across 2 drugs with 11 or more claims each, at $317 in total drug cost. In 2023, CMS named 75 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Muhlert for performance year 2024, reported as part of a group. Dr. Muhlert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of leg revascularization (restoring blood flow) by Dr. Muhlert, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Muhlert.

CMS Open Payments shows 491 general payments to Dr. Muhlert from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Penumbra, Inc. paid the most, $14,574.

Dr. Muhlert graduated from University of Texas Medical School at Houston in 2004.